Data News > Outperform Recommendation Issued On EMR By Wolfe Research

Outperform Recommendation Issued On EMR By Wolfe Research

By KlickAnalytics Data Insights  |   April 8, 2024 03:30PM ET

  • Wolfe Research analyst issues OUTPERFORM recommendation for EMR on April 8, 2024 02:00PM ET.
  • The previous analyst recommendation was Outperform.
  • EMR was trading at $114.89 at issue of the analyst recommendation.
  • The overall analyst consensus : BUY.
  • Current analyst recommendations are : 15 - Buy, 1 - Hold recommendations .

  • Historical Analyst Recommendations
    Latest 10 recommendations
    Report DateAnalyst CompanyActionPrevious GradeNew GradePrice when posted
    2024-04-08 Wolfe Research Hold Outperform Outperform 114.89
    2024-04-08 Citigroup Hold Buy Buy 114.54
    2024-04-04 RBC Capital Hold Outperform Outperform 113.04
    2024-03-06 Canaccord Genuity Hold Buy Buy 109.02
    2024-01-04 Mizuho Securities Upgrade Neutral Buy 95.71
    2023-10-20 CFRA Upgrade Buy 0.00
    2023-09-15 Vertical Research Upgrade Buy 98.83
    2023-06-14 HSBC Upgrade Buy 85.84
    2023-04-20 Wells Fargo Upgrade Equal-Weight Overweight 86.37
    2023-03-21 Morgan Stanley Upgrade Equal-Weight Overweight 83.95

    Historical Price Performance



    For more information:
  • Analyst Recommendations
  • Historical Price Targets
  • Earning Price Impact Analysis
  • Seasonality Analysis
  • This article was generated by KlickAnalytics data insight content engine.

    Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.